Glucosylceramide modulates membrane traffic along the endocytic pathway.

Glucosylceramide modulates membrane traffic along the endocytic pathway.

Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a heredita...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sillence, D, Puri, V, Marks, D, Butters, T, Dwek, R, Pagano, R, Platt, F
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2002

Míreanna comhchosúla

Glucosylceramide modulates membrane traffic along the endocytic pathway
de réir: Dan J. Sillence, et al.
Foilsithe / Cruthaithe: (2002-11-01)

Glycosphingolipids in endocytic membrane transport.
de réir: Sillence, D, et al.
Foilsithe / Cruthaithe: (2004)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
de réir: Norris-Cervetto, E, et al.
Foilsithe / Cruthaithe: (2004)

The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
de réir: Smith, D, et al.
Foilsithe / Cruthaithe: (2006)

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
de réir: Walden, C, et al.
Foilsithe / Cruthaithe: (2007)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
de réir: Norris-Cervetto, E, et al.
Foilsithe / Cruthaithe: (2006)

Rabs, Rips, FIPs, and Endocytic Membrane Traffic
de réir: Rytis Prekeris
Foilsithe / Cruthaithe: (2003-01-01)

Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization.
de réir: Céline Lafourcade, et al.
Foilsithe / Cruthaithe: (2008-07-01)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
de réir: Natsuki Kita, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Small GTPases in post-Golgi and endocytic membrane traffic in Arabidopsis
de réir: Moore, I, et al.
Foilsithe / Cruthaithe: (2008)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
de réir: Boucheron, C, et al.
Foilsithe / Cruthaithe: (2005)

A-RAF kinase functions in ARF6 regulated endocytic membrane traffic.
de réir: Elena Nekhoroshkova, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
de réir: Scott D. Larsen, et al.
Foilsithe / Cruthaithe: (2012-02-01)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
de réir: Mellor, H, et al.
Foilsithe / Cruthaithe: (2003)

Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide.
de réir: D'Angelo, G, et al.
Foilsithe / Cruthaithe: (2007)

Membrane order in the plasma membrane and endocytic recycling compartment.
de réir: David B Iaea, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
de réir: Boucheron, C, et al.
Foilsithe / Cruthaithe: (2005)

Glycosphingolipid changes in plasma in Parkinson’s disease independent of glucosylceramide levels
de réir: te Vruchte, D, et al.
Foilsithe / Cruthaithe: (2022)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
de réir: Neville, D, et al.
Foilsithe / Cruthaithe: (2004)

Assay for the transbilayer distribution of glycolipids: selective oxidation of glucosylceramide to glucuronylceramide by TEMPO nitroxyl radicals
de réir: Daniel J. Sillence, et al.
Foilsithe / Cruthaithe: (2000-08-01)

Invariant chain regulation of MHC class II function in the secretory and endocytic pathways
de réir: Germain, R, et al.
Foilsithe / Cruthaithe: (1997)

Glucosylceramides of pig epidermis: structure determination.
de réir: P W Wertz, et al.
Foilsithe / Cruthaithe: (1983-09-01)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
de réir: Garner, B, et al.
Foilsithe / Cruthaithe: (2002)

Editorial: Signaling Control by Compartmentalization Along the Endocytic Route
de réir: Costin N. Antonescu, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion.
de réir: Tian Xia, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion
de réir: Tian Xia, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase
de réir: Misbaudeen Abdul-Hammed, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Sitosterol and glucosylceramide cooperative transversal and lateral uneven distribution in plant membranes
de réir: V. Rondelli, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
de réir: Butters, T, et al.
Foilsithe / Cruthaithe: (2005)

Therapeutic applications of imino sugars in lysosomal storage disorders.
de réir: Butters, T, et al.
Foilsithe / Cruthaithe: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
de réir: Butters, T, et al.
Foilsithe / Cruthaithe: (2005)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
de réir: Butters, T, et al.
Foilsithe / Cruthaithe: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
de réir: Butters, T, et al.
Foilsithe / Cruthaithe: (2000)

Inhibition of membrane-associated viral replication
de réir: Block, T, et al.
Foilsithe / Cruthaithe: (2016)

Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C disease
de réir: Simon Wheeler, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Imino sugar therapy for type 1 Gaucher disease.
de réir: Priestman, D, et al.
Foilsithe / Cruthaithe: (2000)

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
de réir: Sonya Barnes, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Membrane binding of plasmid DNA and endocytic pathways are involved in electrotransfection of mammalian cells.
de réir: Mina Wu, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
de réir: Gerrard, G, et al.
Foilsithe / Cruthaithe: (2009)

Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing
de réir: Michaela Sochorová, et al.
Foilsithe / Cruthaithe: (2017-07-01)